Abstract. Multiple intravenous injections of an emulsion containing 7,12-dimethylbenz(a)anthracene (DMIBA) or 7,8,12-trimethylbenz(a)anthracene (TMBA) induce a high incidence of leukemia in rats. Twenty-four hours after a single injection, about half of the metaphase cells in the marrow have chromosomes with breaks. Although breaks were inflicted on chromosomes of various sizes and morphology, these aberrations were nonrandom in that members of the nos. 1 and 2 chromosome pairs were involved to an extent greater than expected on the basis of their size and number. Distinctive karyotypic abnormalities involving the no. 2 chromosome were observed in half of the leukemic rats, whereas these abnormalities were not observed in nonleukemic, DMBA-treated rats. Benzo(a)pyrene and benzo(e)pyrene, polycyclic aromatic hydrocarbons which did not induce leukemia, produced fewer breaks of the no. 2 (and other) chromosomes than did DMIBA or TMIBA.
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The experimental leukemias of rats are of special interest, since spontaneous leukemia rarely occurs in rats but can be induced by radiation and by chemicalsparticularly the polycyclic aromatic hydrocarbon carcinogens 3-methylcholanthrene, 7,12-dimethylbenz(a)anthracene (DMNIBA), and 7,8,12-trimethylbenz(a)anthracene (TMBA). Despite considerable interest in the chromosomes of leukemic cells and in chromosomal theories of oncogenesis, only scanty data1'3 exist concerning the chromosome changes occurring in marrow pair of chromosomes is usually heteromorphic,9 one member is a st and the other is a t chromosome.
Results. Initial changes: After the rats had been injected with DM\IBA, the most striking and distinctive observation was the presence of chromatid and (to a lesser extent) isochromatid breaks on the chromosomes of the marrow cells (Fig. 1) . The appearance of these lesions was quite rapid. At 22 hr, 5%0 of the cells had one or more chromosomes containing a break, and at 4, 6, and 24 hr the incidence was 25, 45, and 43%0, respectively. Thus, maximum incidence was reached within 6-24 hr. Isochromatid breaks constituted 25% of the total breaks. The incidence of these aberrations increased with DMIBA dose as has also been shown by Kurita et al.' Breaks were observed only rarely (less than 1%) in untreated rats of either the Long-Evans or Sprague-Dawley strains. Control rats receiving intravenous emulsion without DMBA had a 3%0 or less incidence of breaks in marrow cells. In the case of gaps, it was not unusual to find these narrow, sharp, achromatic bands on the chromatids of some chromosomes from some untreated rats. Breaks were visually distinguished from gaps by the displacement (greater separation or malalignment) of the two chromatid pieces and by uneveness of the edges of the breaks. (The interpretation of gaps has been a matter of controversy which is well discussed by Revell,'0 Evans," and Kihiman;"2 a concise description of present theories of chromosomal aberrations is also found in Rieger et al. 13) After the DMBA injection, the incidence of gaps was about the same as for breaks; however, even untreated control animals may have a substantial incidence of gaps. Fragments, occasional dicentrics, and an increased incidence of gaps accompanied the breaks; however, interchanges of chromatids between chromosomes, such as observed by Kato14'15 in hamster cells exposed to DMBA, were seen only rarely-no more than four times in over 1000 cells from our intravenously DMBA-treated rats. The percentage of cells having at least one chromosome with one or more breaks was plotted versus time after injection. After the first dose 2-3 days were required for the incidence of these lesions to decay to half the initial 24-hr value. By the tenth day the incidence had approached the level of the controls. Subsequent injections on day 10 and on day 20 again increased the incidence of breaks. After the third injection many animals showed a persistence of these aberrations. The effects of other polycyclic aromatic hydrocarbons (given in the same dose as the DMBA) on marrow cell chromosomes were also studied 24 hr after intravenous injection. TMBA, an extremely potent leukemogen, produced breaks in 55% of metaphase cells; whereas, benzo(a)pyrene and benzo(e)pyrene produced breaks in 21 and 11%, respectively. (In the rat, benzo(a)pyrene is not nearly so carcinogenic as DMBA or TMBA, and BeP may be noncarcinogenic; neither benzo(a)pyrene nor benzo(e)pyrene has produced leukemia in our rats.) The location of breaks on individual chromosomes were recorded for each compound, and the total number of breaks observed on a given type of chromosome was divided by the total number of chromosomes of that type analyzed. Figure  2 depicts these data and, in addition, delineates the were not uncommon. Although no breaks were seen in chromosomes from leukemic rat B, the incidence of breaks in the other leukemic animals ranged from 6 to 17%.
Control groups: In addition to the leukemic animals and the animals studied within 1 day to 2 weeks after intravenous injection of DMBA, three other groups of animals (Table 1) were studied for comparison: (a) 14 untreated animals, (b) 16 animals receiving intravenous lipid emulsion without DMBA, and (c) 11 that received DMXIBA intravenously but were not leukemic. The animals in the latter group were sacrificed 2-7 months after their first DM\1BA dose, during the time that their leukemic partners were studied. Table 1 also indicates the chromosome number distribution for 40 of the rats which were sacrificed within 2 weeks after the last intravenous dose of DMBA. Of the 10 (one animal was not studied) intravenously injected DM\BA treated nonleukemic rats, six had cells possessing chromosomes with breaks in an incidence of 5-15%.
Discussion. Chromosomal aberrations have been commonly observed in cells from neoplasms, and there has been much discussion as to whether the aberrations are a cause or a consequence of neoplastic disease. For a causal relation to exist it would seem necessary, though not sufficient, that aberrations occur prior to the onset of overt disease. As demonstrated above, DMBA administered intravenously to rats produced considerable damage, particularly breaks, in marrow cell chromosomes in a matter of hours, and leukemia developed later over a period of weeks. -Moreover, the damage w-as nonrandom, the largest st and t chromosomes were especially vulnerable to break formation. After the first and second injection, cells with breaks had an apparent half-life of 2-3 days in the marrow. Whether these cells left the marrow not to return, or were not viable, or for other reasons did not reach metaphase in the marrow again is not known. However, after the third DM\IBA injection, cells with aberrant chromosomes were persistently present in the marrow. In this regard, it is of interest that [4] [5] [6] In order to form a neoplastic cell, a subtle lesion would have to be present in the appropriate position(s) on a specific chromosome(s). Since our data indicate that breaks are unduly frequent on the nos. 1 and 2 chromosomes (possibly because of a greater "affinity" of these chromosomes for DMWBA and TMBA, or a greater intrinsic vulnerability per se of these chromosomes to damage by these compounds), subtle lesions presumably would also be more common on these chromosomes. However, our concept also requires that the cell must not be rendered inviable or nonproliferative by additional damage elsewhere. These are demanding requirements; even though the nos. 1 and 2 chromosomes are preferentially involved with breaks, they are not uniquely involved. In fact, our findings indicate rather widespread damage to other chromosomes and the extent of nonchromosomal damage to cells has not been determined. Also, a "leukemicized" cell must not succumb to host defenses, if leukemia is to occur. Such considerations suggest that the proper combination of cell damage and favorable environment must be a rather rare event; a view which is in accord with the observation that, despite many cells in the marrow and a high incidence of damage to these cells following DMIBA or TMBA, in a substantial proportion of leukemic hosts a distinctive abnormality is found in a high proportion of metaphase cells. 
